Corporations Act 2001
Note: This Chapter applies to a CCIV in a modified form: see Division 4 of Part 8B.7 .
Ch 7 amended by No 8 of 2022, s 3, Sch 2[165] (effective 1 July 2022).
Ch 7 inserted by No 122 of 2001, s 3, Sch 1, Pt 1 [ 1].
As Act No 122 of 2001 repealed Ch 7 and 8 the history notes for Ch 7 use " inserted " and references to the former provisions have been removed.
Pt 7.9 heading amended by No 141 of 2003, s 3, Sch 1 [ 2] (effective 14 January 2004).
CCH Note: Division 2 is modified by the ASIC Corporations (Incidental Retail Cover) Instrument 2022/716; the ASIC Corporations (Removing Barriers to Electronic Disclosure) Instrument 2015/649; the ASIC Corporations (Shorter PDS and Delivery of Accessible Financial Products Disclosure by Platform Operators and Superannuation Trustees) Instrument 2022/497; the ASIC Corporations (Investor Directed Portfolio Services Provided Through a Registered Managed Investment Scheme) Instrument 2023/668; and the ASIC Corporations (Investor Directed Portfolio Services) Instrument 2023/669.
CCH Note: Subdivision C is modified by the ASIC Corporations (Incidental Retail Cover) Instrument 2022/716; the ASIC Corporations (Removing Barriers to Electronic Disclosure) Instrument 2015/649; the ASIC Corporations (Shorter PDS and Delivery of Accessible Financial Products Disclosure by Platform Operators and Superannuation Trustees) Instrument 2022/497; the ASIC Corporations (Investor Directed Portfolio Services Provided Through a Registered Managed Investment Scheme) Instrument 2023/668; the ASIC Corporations (Investor Directed Portfolio Services) Instrument 2023/669; and the ASIC Corporations (Discretions for Setting the Issue Price and Withdrawal Price of Interests in Managed Investment Schemes) Instrument 2023/693.
CCH Note: Section 1013I is modified by the ASIC Corporations (Incidental Retail Cover) Instrument 2022/716; the ASIC Corporations (Removing Barriers to Electronic Disclosure) Instrument 2015/649; the ASIC Corporations (Shorter PDS and Delivery of Accessible Financial Products Disclosure by Platform Operators and Superannuation Trustees) Instrument 2022/497; the ASIC Corporations (Investor Directed Portfolio Services Provided Through a Registered Managed Investment Scheme) Instrument 2023/668; the ASIC Corporations (Investor Directed Portfolio Services) Instrument 2023/669; and the ASIC Corporations (Discretions for Setting the Issue Price and Withdrawal Price of Interests in Managed Investment Schemes) Instrument 2023/693.
This section applies to a Product Disclosure Statement that relates to managed investment products that are ED securities.
1013I(2)
The Product Disclosure Statement must include a statement that: (a) as a disclosing entity, the scheme is subject to regular reporting and disclosure obligations; and (b) copies of documents lodged with ASIC in relation to the scheme may be obtained from, or inspected at, an ASIC office.
[ CCH Note: S 1013I(2) will be amended by No 69 of 2020, s 3, Sch 1[1170], by substituting para (b) (effective 1 July 2026 or a day or days to be fixed by Proclamation). Para (b) will read:
(b) the Registrar provides access to copies of documents lodged with the Registrar in relation to the scheme.]
1013I(3)
The Product Disclosure Statement must either: (a) inform people of their right to obtain a copy of the following documents:
(i) the annual financial report most recently lodged with ASIC by the scheme;
(ii) any half-year financial report lodged with ASIC by the scheme after the lodgment of that annual financial report and before the date of the Product Disclosure Statement;
(b) include, or be accompanied by, a copy of the relevant document or documents.
(iii) any continuous disclosure notices given by the scheme after the lodgment of that annual report and before the date of the Product Disclosure Statement; or
[ CCH Note: S 1013I(3) will be amended by No 69 of 2020, s 3, Sch 1[1171], by substituting " the Registrar " for " ASIC " in para (a)(i) and (ii) (effective 1 July 2026 or a day or days to be fixed by Proclamation).]
1013I(4)
If: (a) the Product Disclosure Statement informs people of their right to obtain a copy of a document referred to in subsection (3); and (b) a person asks the issuer (in the case of an issue Statement) or the seller (in the case of a sale Statement) for a copy of the document;
the issuer or seller must give (see subsection (5) ) the person a copy of the document free of charge as soon as practicable, and in any event within 5 days, after receiving the person's request.
Note: Failure to comply with this subsection is an offence (see subsection 1311(1) ).
1013I(5)
In subsection (4) , give means give in a way that would satisfy the requirements of section 1015C if the copy of the document were a Statement to which that section applied.
S 1013I inserted by No 122 of 2001, s 3, Sch 1, Pt 1 [ 1].
Disclaimer and notice of copyright applicable to materials provided by CCH Australia Limited
CCH Australia Limited ("CCH") believes that all information which it has provided in this site is accurate and reliable, but gives no warranty of accuracy or reliability of such information to the reader or any third party. The information provided by CCH is not legal or professional advice. To the extent permitted by law, no responsibility for damages or loss arising in any way out of or in connection with or incidental to any errors or omissions in any information provided is accepted by CCH or by persons involved in the preparation and provision of the information, whether arising from negligence or otherwise, from the use of or results obtained from information supplied by CCH.
The information provided by CCH includes history notes and other value-added features which are subject to CCH copyright. No CCH material may be copied, reproduced, republished, uploaded, posted, transmitted, or distributed in any way, except that you may download one copy for your personal use only, provided you keep intact all copyright and other proprietary notices. In particular, the reproduction of any part of the information for sale or incorporation in any product intended for sale is prohibited without CCH's prior consent.